[HTML][HTML] Therapeutic host-directed strategies to improve outcome in tuberculosis
Abstract Bacille Calmette-Guérin (BCG) is the only licenced tuberculosis (TB) vaccine, but
has limited efficacy against pulmonary TB disease development and modest protection …
has limited efficacy against pulmonary TB disease development and modest protection …
Host defense mechanisms against Mycobacterium tuberculosis
Q Chai, Z Lu, CH Liu - Cellular and Molecular Life Sciences, 2020 - Springer
Tuberculosis (TB), which is caused by Mycobacterium tuberculosis (Mtb), remains the
leading cause of death worldwide from a single infectious pathogen. Mtb is a paradigmatic …
leading cause of death worldwide from a single infectious pathogen. Mtb is a paradigmatic …
Natural compounds and glutathione: Beyond mere antioxidants
The tripeptide glutathione plays important roles in many cell processes, including
differentiation, proliferation, and apoptosis; in fact, disorders in glutathione homeostasis are …
differentiation, proliferation, and apoptosis; in fact, disorders in glutathione homeostasis are …
[HTML][HTML] New roles for glutathione: Modulators of bacterial virulence and pathogenesis
JWK Ku, YH Gan - Redox Biology, 2021 - Elsevier
Low molecular weight (LMW) thiols contain reducing sulfhydryl groups that are important for
maintaining antioxidant defense in the cell. Aside from the traditional roles of LMW thiols as …
maintaining antioxidant defense in the cell. Aside from the traditional roles of LMW thiols as …
A Randomized controlled trial of intravenous N-acetylcysteine in the management of anti-tuberculosis drug–induced liver injury
MS Moosa, G Maartens, H Gunter, S Allie… - Clinical Infectious …, 2021 - academic.oup.com
Background Liver injury is a common complication of anti-tuberculosis therapy. N-
acetylcysteine (NAC) used in patients with paracetamol toxicity with limited evidence of …
acetylcysteine (NAC) used in patients with paracetamol toxicity with limited evidence of …
Pathogenesis of Human Immunodeficiency Virus-Mycobacterium tuberculosis Co-Infection
K Wong, J Nguyen, L Blair, M Banjanin… - Journal of clinical …, 2020 - mdpi.com
Given that infection with Mycobacterium tuberculosis (Mtb) is the leading cause of death
amongst individuals living with HIV, understanding the complex mechanisms by which Mtb …
amongst individuals living with HIV, understanding the complex mechanisms by which Mtb …
Modulating macrophage function to reinforce host innate resistance against Mycobacterium avium complex infection
HE Park, W Lee, S Choi, M Jung, MK Shin… - Frontiers in …, 2022 - frontiersin.org
Mycobacterium avium complex (MAC) is the main causative agent of infectious diseases in
humans among nontuberculous mycobacteria (NTM) that are ubiquitous organisms found in …
humans among nontuberculous mycobacteria (NTM) that are ubiquitous organisms found in …
A review on recent advances in nanomedicines for the treatment of pulmonary tuberculosis
Tuberculosis (TB) has been the most life-threatening contagious disease caused by
pathogenic mycobacterium tuberculosis. The World Health Organization (WHO) report, 2020 …
pathogenic mycobacterium tuberculosis. The World Health Organization (WHO) report, 2020 …
Antimycobacterial effects of everolimus in a human granuloma model
D Ashley, J Hernandez, R Cao, K To… - Journal of Clinical …, 2020 - mdpi.com
Mycobacterium tuberculosis (M. tb) has been historically and is currently a threat to global
public health. First-line antibiotics have been effective but proven to be burdensome as they …
public health. First-line antibiotics have been effective but proven to be burdensome as they …
Investigating the Role of Everolimus in mTOR Inhibition and Autophagy Promotion as a Potential Host-Directed Therapeutic Target in Mycobacterium tuberculosis …
S Cerni, D Shafer, K To, V Venketaraman - Journal of Clinical Medicine, 2019 - mdpi.com
Tuberculosis (TB) is a serious infectious disease caused by the pathogen Mycobacterium
tuberculosis (Mtb). The current therapy consists of a combination of antibiotics over the …
tuberculosis (Mtb). The current therapy consists of a combination of antibiotics over the …